Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function

Publication ,  Conference
Kohn, DB; Shaw, KL; Garabedian, E; Carbonaro-Sarracino, DA; Moore, TB; De Oliveira, S; Crooks, GM; Tse, J; Shupien, S; Terrazas, D; Davila, A ...
Published in: JOURNAL OF CLINICAL IMMUNOLOGY
2019

Duke Scholars

Published In

JOURNAL OF CLINICAL IMMUNOLOGY

EISSN

1573-2592

ISSN

0271-9142

Publication Date

2019

Volume

39

Start / End Page

S44 / S45

Related Subject Headings

  • Immunology
  • 3204 Immunology
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kohn, D. B., Shaw, K. L., Garabedian, E., Carbonaro-Sarracino, D. A., Moore, T. B., De Oliveira, S., … Gaspar, H. B. (2019). Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function. In JOURNAL OF CLINICAL IMMUNOLOGY (Vol. 39, pp. S44–S45).
Kohn, Donald B., Kit L. Shaw, Elizabeth Garabedian, Denise A. Carbonaro-Sarracino, Theodore B. Moore, Satiro De Oliveira, Gay M. Crooks, et al. “Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function.” In JOURNAL OF CLINICAL IMMUNOLOGY, 39:S44–45, 2019.
Kohn DB, Shaw KL, Garabedian E, Carbonaro-Sarracino DA, Moore TB, De Oliveira S, et al. Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function. In: JOURNAL OF CLINICAL IMMUNOLOGY. 2019. p. S44–5.
Kohn DB, Shaw KL, Garabedian E, Carbonaro-Sarracino DA, Moore TB, De Oliveira S, Crooks GM, Tse J, Shupien S, Terrazas D, Davila A, Icreverzi A, Yu A, Barman PI, Coronel M, Fernandez BC, Zhang R, Hollis R, Uzowuru C, Ricketts H, Bayford JX, Trevisan V, Arduini S, Lynn F, Kudari M, Spezzi A, Reeves L, Cornetta K, Sokolic R, Parrott R, Buckley R, Booth C, Candotti F, Malech H, Thrasher AJ, Gaspar HB. Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function. JOURNAL OF CLINICAL IMMUNOLOGY. 2019. p. S44–S45.
Journal cover image

Published In

JOURNAL OF CLINICAL IMMUNOLOGY

EISSN

1573-2592

ISSN

0271-9142

Publication Date

2019

Volume

39

Start / End Page

S44 / S45

Related Subject Headings

  • Immunology
  • 3204 Immunology
  • 1107 Immunology